The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott | Common | 002824100 | 16,894,522 | 166,843 | SH | SOLE | 166,843 | 0 | 0 | ||
Abbvie | Common | 00287Y109 | 30,558,082 | 191,743 | SH | SOLE | 191,743 | 0 | 0 | ||
Allstate | Common | 020002101 | 18,487,984 | 166,844 | SH | SOLE | 166,844 | 0 | 0 | ||
Uhaul | Common | 023586100 | 4,459,673 | 74,764 | SH | SOLE | 74,764 | 0 | 0 | ||
Uhaul B | Common | 023586506 | 33,211,480 | 640,530 | SH | SOLE | 640,530 | 0 | 0 | ||
Apple | Common | 037833100 | 10,520,785 | 63,801 | SH | SOLE | 63,801 | 0 | 0 | ||
Ashland | Common | 044209104 | 1,540,650 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
Avista | Common | 05379B107 | 8,702,250 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
Caribu Biosciences | Common | 142038108 | 531,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CMS Energy | Common | 125896100 | 25,580,422 | 416,755 | SH | SOLE | 416,755 | 0 | 0 | ||
Acorda Theraputics | Cv 6.0% | 00484MAB2 | 3,250,455 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
Accelerate Diagnostic | Cv 2.5% | 00430HAB8 | 2,773,125 | 3,000,000 | PRN | SOLE | 3,000,000 | 0 | 0 | ||
Duke Energy | Common | 26441C204 | 25,112,974 | 260,319 | SH | SOLE | 260,319 | 0 | 0 | ||
EDAP | Common | 268311107 | 6,261,768 | 565,652 | SH | SOLE | 565,652 | 0 | 0 | ||
Fate Theraputics | Common | 31189P102 | 1,140,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AT & T | Common | 00206R102 | 21,757,390 | 1,130,254 | SH | SOLE | 1,130,254 | 0 | 0 | ||
Warner Bros. Discovery | Common | 934423104 | 223,646 | 14,811 | SH | SOLE | 14,811 | 0 | 0 | ||
Nextera Energy | Common | 302571104 | 26,601,387 | 345,114 | SH | SOLE | 345,114 | 0 | 0 | ||
Kodiak Sciences | Common | 50015M109 | 2,932,600 | 473,000 | SH | SOLE | 473,000 | 0 | 0 | ||
Personalis | Common | 71535D106 | 414,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
908 Devices | Common | 65443P102 | 587,260 | 68,286 | SH | SOLE | 68,286 | 0 | 0 | ||
Lava Theraputics | Common | N51517105 | 1,115,311 | 671,874 | SH | SOLE | 671,874 | 0 | 0 | ||
Newmont | Common | 651639106 | 3,215,712 | 65,600 | SH | SOLE | 65,600 | 0 | 0 | ||
IGM Bioscience | Common | 449585108 | 755,700 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
Insteel | Common | 45774W108 | 9,554,028 | 343,423 | SH | SOLE | 343,423 | 0 | 0 | ||
Organon | Common | 68622V106 | 740,174 | 31,470 | SH | SOLE | 31,470 | 0 | 0 | ||
Mannkind | Common | 56400P706 | 799,799 | 195,073 | SH | SOLE | 195,073 | 0 | 0 | ||
Merck | Common | 589331107 | 31,956,577 | 300,372 | SH | SOLE | 300,372 | 0 | 0 | ||
Paratek | Cv 4.75% | 699374AA2 | 12,280,252 | 16,600,000 | PRN | SOLE | 16,600,000 | 0 | 0 | ||
Paratek | Common | 699374302 | 3,952,867 | 1,556,247 | SH | SOLE | 1,556,247 | 0 | 0 | ||
Pfizer | Common | 717081103 | 21,975,941 | 538,626 | SH | SOLE | 538,626 | 0 | 0 | ||
RLI | Common | 749607107 | 318,984 | 2,400 | SH | SOLE | 2,400 | 0 | 0 | ||
Supernus | Common | 868459108 | 2,974,664 | 82,105 | SH | SOLE | 82,105 | 0 | 0 | ||
Viatris | Common | 92556V106 | 572,765 | 59,539 | SH | SOLE | 59,539 | 0 | 0 | ||
Bausch Health | Common | 91911K102 | 7,498,818 | 925,780 | SH | SOLE | 925,780 | 0 | 0 | ||
XM Sirius | Common | 82968B103 | 2,611,637 | 657,843 | SH | SOLE | 657,843 | 0 | 0 | ||
XEL Energy | Common | 98389B100 | 25,071,090 | 371,754 | SH | SOLE | 371,754 | 0 | 0 |